← back to search

Milind Mahajan

Icahn School of Medicine at Mount Sinai · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer Genomics and Diagnostics, RNA modifications and cancer, Genomics and Chromatin Dynamics, and Genomics and Rare Diseases.
h-index
38
citations
11,476
works
110
NIH funding
primary concept
email

Recent publications

A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery
Nature Communications 2021cited by 41position: middledoi
A library of induced pluripotent stem cells from clinically well-characterized, diverse healthy human individuals
Stem Cell Reports 2021cited by 29position: middledoi
Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap
Science 2018cited by 1,144position: middledoi
The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease
Scientific Data 2018cited by 599position: middledoi
Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS
The American Journal of Human Genetics 2018cited by 171position: middledoi
Large-Scale Identification of Common Trait and Disease Variants Affecting Gene Expression
The American Journal of Human Genetics 2017cited by 97position: middledoi
Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas
Nature Communications 2017cited by 87position: middledoi
Gene expression elucidates functional impact of polygenic risk for schizophrenia
Nature Neuroscience 2016cited by 1,211position: middledoi
Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia
bioRxiv (Cold Spring Harbor Laboratory) 2016cited by 48position: middledoi
De novo mutations in schizophrenia implicate synaptic networks
Nature 2014cited by 1,696position: middledoi
Most genetic risk for autism resides with common variation
Nature Genetics 2014cited by 1,279position: middledoi
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration
Gut 2014cited by 75position: middledoi
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Cell 2013cited by 1,759position: middledoi
RNA-Seq Profiling of Spinal Cord Motor Neurons from a Presymptomatic SOD1 ALS Mouse
PLoS ONE 2013cited by 74position: middledoi
Genome-wide mapping of methylated adenine residues in pathogenic Escherichia coli using single-molecule real-time sequencing
Nature Biotechnology 2012cited by 379position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sven Sandin · Karolinska Institutet1 papers (2014–2014)Diana Munera · Harvard University1 papers (2012–2012)Yujin Hoshida · WinnMed1 papers (2014–2014)Ann B. Lee · Carnegie Mellon University1 papers (2014–2014) · 1 papers (2014–2014)Yudi Pawitan · Karolinska Institutet1 papers (2014–2014) · 1 papers (2014–2014)Wayne A. Fenton · Yale University1 papers (2013–2013)Brigid M. Davis · Brigham and Women's Hospital1 papers (2012–2012)Raymond T. Chung · Harvard University1 papers (2014–2014)Bernie Devlin · University of Pittsburgh1 papers (2014–2014)Maria Isabel Fiel · Mount Sinai Hospital1 papers (2014–2014)Steve Turner · Utrecht University1 papers (2012–2012) · 1 papers (2014–2014)Michael C. Chao · Center for Disease Dynamics, Economics & Policy1 papers (2012–2012)Kensuke Kojima · NHO Kinki Chuo Chest Medical Center1 papers (2014–2014)Tyson A. Clark · University of California, Santa Cruz1 papers (2012–2012)Andrew Chess · Allen Institute for Brain Science1 papers (2012–2012) · 1 papers (2012–2012)Angelo Sangiovanni · University of Campania "Luigi Vanvitelli"1 papers (2014–2014)